In CLL cells of asymptomatic, previously untreated patients, TRERNA1 was found to be overexpressed when compared to normal B cells and high expression level was associated with unfavorable prognostic markers (unmutated IGHV, high ZAP70 expression) and with shorter time to first treatment [144]. The gene discussed is TRERNA1; the disease is B-cell chronic lymphocytic leukemia.